These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8524928)

  • 1. Quantitative variations in beta-lactam antibiotic released endotoxin from Pseudomonas aeruginosa: in-vivo relevance.
    Jackson JJ; Kropp H
    Prog Clin Biol Res; 1995; 392():235-51. PubMed ID: 8524928
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential release of endotoxin from Pseudomonas aeruginosa treated with beta-lactam antibiotics and its effect on the lethal activity.
    Narita K; Koide N; Morikawa A; Kato Y; Sugiyama T; Yoshida T; Yokochi T
    Jpn J Med Sci Biol; 1997 Dec; 50(6):233-9. PubMed ID: 9789786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
    Ludwig E; Konkoly-Thege M; Kuti JL; Nicolau DP
    Int J Antimicrob Agents; 2006 Nov; 28(5):433-8. PubMed ID: 17046212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital.
    Jung R; Fish DN; Obritsch MD; MacLaren R
    J Hosp Infect; 2004 Jun; 57(2):105-11. PubMed ID: 15183239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid development of auricular infection due to imipenem-resistant Pseudomonas aeruginosa following self-administered piercing of high ear.
    Vargas J; Carballo M; Hernández M; Rojas N; Jiménez O; Riera J; Romero L; Rodriguez-Morales AJ; Silva M
    Clin Infect Dis; 2005 Dec; 41(12):1823-4. PubMed ID: 16288414
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological change in Pseudomonas aeruginosa following antibiotic treatment of experimental infection in mice and its relation to susceptibility to phagocytosis and to release of endotoxin.
    Yokochi T; Narita K; Morikawa A; Takahashi K; Kato Y; Sugiyama T; Koide N; Kawai M; Fukada M; Yoshida T
    Antimicrob Agents Chemother; 2000 Jan; 44(1):205-6. PubMed ID: 10602751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem.
    Yamano Y; Nishikawa T; Fujimura T; Yutsudou T; Tsuji M; Miwa H
    J Antibiot (Tokyo); 2006 Dec; 59(12):791-6. PubMed ID: 17323646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of meropenem against Pseudomonas aeruginosa, including antibiotic-induced morphological changes and endotoxin-liberating effects.
    Trautmann M; Heinemann M; Zick R; Möricke A; Seidelmann M; Berger D
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):754-60. PubMed ID: 9923514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.
    Majumdar S; Kirby A; Berry N; Williams C; Hassan I; Eddleston J; Burnie JP
    J Hosp Infect; 2004 Oct; 58(2):160-1. PubMed ID: 15474190
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An experimental study of the LPS release from gram-negative bacteria induced by antibiotics (Part two)].
    Xu N; Yuan J; Xiao G; Zheng J; Qin X
    Zhonghua Shao Shang Za Zhi; 2002 Apr; 18(2):92-4. PubMed ID: 12515654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of resistance in Pseudomonas aeruginosa].
    Cercenado Mansilla E; García Garrote F
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():10-6. PubMed ID: 9844472
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antipyocyanic antibiotic therapy. Principles and efficacy factors].
    Cohen R
    Arch Pediatr; 2006 Oct; 13 Suppl 1():S10-2. PubMed ID: 17370390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pseudomonas aeruginosa: a multicentric study of antibiotic resistance (1999-2000)].
    Kalai S; Jouaihia W; Mahjoubi F; Ghozzi R; Thabet L; Ben Rejeb S; Hammami A; Kechrid A; Ben Hassen A
    Tunis Med; 2004 Dec; 82(12):1070-4. PubMed ID: 15822507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem-induced resistance to beta-lactams in Pseudomonas aeruginosa.
    Giacometti A; Del Prete MS; Cirioni O; Izat MK; Balducci M; Cesarini AM; Scalise G
    J Chemother; 1995 Nov; 7 Suppl 4():76-7. PubMed ID: 8904115
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital.
    Sasaki M; Hiyama E; Takesue Y; Kodaira M; Sueda T; Yokoyama T
    J Hosp Infect; 2004 Feb; 56(2):111-8. PubMed ID: 15019222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
    Martins AF; Zavascki AP; Gaspareto PB; Barth AL
    Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.